Skip to main content
Screener/Healthcare/Biotechnology

ARWR — Arrowhead Pharmaceuticals, Inc.

NASDAQ
$72.07+3.25 (+4.73%)
Mid CapHealthcare
$31.45
$95.49
$68.08
$72.36
EPS (TTM)$-2.14
P/E Ratio51.38
Dividend Yield—
Market Cap$9.36B
Volume1.57M
Prev Close$68.79
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q2 '26$73.7M-$132.7M$-0.930.0%-180.0%
Q1 '26$264.0M$30.8M$0.2297.6%11.7%
Q4 '25$256.5M-$23.8M$-0.1797.5%-9.3%
Q3 '25$27.8M-$175.2M$-1.2677.6%-631.1%
Q2 '25$542.7M$370.4M$2.7598.9%68.3%
Q1 '25$2.5M-$173.1M$-1.39-109.4%-6923.4%
Q4 '24$0-$170.5M$-1.40——
Q3 '24$0-$170.8M$-1.38——
Get Your Daily Market Recap